AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 69 filers reported holding AADI BIOSCIENCE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,791,106 | -29.2% | 2,849,402 | 0.0% | 0.22% | -18.6% |
| Q2 2023 | $19,489,910 | -5.5% | 2,849,402 | 0.0% | 0.26% | -13.7% |
| Q1 2023 | $20,629,670 | -43.6% | 2,849,402 | 0.0% | 0.31% | -44.0% |
| Q4 2022 | $36,557,828 | -9.2% | 2,849,402 | 0.0% | 0.55% | -26.6% |
| Q3 2022 | $40,262,000 | +78.6% | 2,849,402 | +55.8% | 0.74% | +67.2% |
| Q2 2022 | $22,538,000 | -27.4% | 1,829,402 | 0.0% | 0.44% | -21.5% |
| Q1 2022 | $31,045,000 | -29.7% | 1,829,402 | 0.0% | 0.57% | -24.6% |
| Q4 2021 | $44,180,000 | -17.8% | 1,829,402 | 0.0% | 0.75% | -10.9% |
| Q3 2021 | $53,730,000 | – | 1,829,402 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $182,395 | 24.91% |
| Alerce Investment Management, L.P. | 1,630,830 | $11,154,877 | 14.51% |
| ACUTA CAPITAL PARTNERS, LLC | 1,849,402 | $12,649,910 | 8.57% |
| Decheng Capital Management III (Cayman), LLC | 526,329 | $3,600,090 | 1.13% |
| Knott David M Jr | 261,000 | $1,785 | 0.71% |
| Ghost Tree Capital, LLC | 250,000 | $1,710,000 | 0.56% |
| Affinity Asset Advisors, LLC | 187,675 | $1,283,697 | 0.45% |
| Vivo Capital, LLC | 509,572 | $6,456,277 | 0.45% |
| Avoro Capital Advisors LLC | 2,849,402 | $19,489,910 | 0.26% |
| Lion Point Capital, LP | 82,423 | $563,773 | 0.26% |